Sodium-Glucose Cotransporter 2 Inhibitor

Established Pharmacologic Class (EPC) Comparison, United States, 2018

Total Prescriptions in (2018)

Drug Name	Total Prescriptions (2018)	Percent Share
Canagliflozin	3,108,373	38.6%
Empagliflozin	2,649,792	32.9%
Dapagliflozin	2,304,573	28.6%

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2008-2018. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 21.2. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Follow Us!

Get Email Updates

New and Popular

Open Menu

Cite This Page

Show AMA citation

RxHero - Gamified learning for the Top 250 Drugs

Home
Academy
Blog
About

Disclaimer - Privacy Policy - Contact Us
Updated Jan 18, 2021

Top